Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

June 01, 1995; Volume 23,Issue 6
  • You have access
    Urine chromium screening.
    J A Fagliano, M Gochfeld, J E Savrin and A H Stern
    Drug Metabolism and Disposition June 1995, 23 (6) 607-609;
  • You have access
    Cytochrome P4502D isozymes catalyze the 4-hydroxylation of methamphetamine enantiomers.
    L Y Lin, Y Kumagai, A Hiratsuka, S Narimatsu, T Suzuki, Y Funae, E W Distefano and A K Cho
    Drug Metabolism and Disposition June 1995, 23 (6) 610-614;
  • You have access
    Metabolism of cyclosporin G in the mouse, rat, and dog.
    J B Mangold, L C Rodriguez and Y K Wang
    Drug Metabolism and Disposition June 1995, 23 (6) 615-621;
  • You have access
    Glutathione depletion kinetics with acetaminophen. A simulation study.
    M Chiba and K S Pang
    Drug Metabolism and Disposition June 1995, 23 (6) 622-630;
  • You have access
    Metabolism of terfenadine associated with CYP3A(4) activity in human hepatic microsomes.
    K H Ling, G A Leeson, S D Burmaster, R H Hook, M K Reith and L K Cheng
    Drug Metabolism and Disposition June 1995, 23 (6) 631-636;
  • You have access
    Input rate-dependent stereoselective pharmacokinetics. Experimental evidence in verapamil-infused isolated rat livers.
    R Mehvar and J Reynolds
    Drug Metabolism and Disposition June 1995, 23 (6) 637-641;
  • You have access
    Regulation of the Ah gene battery via Ah receptor-dependent and independent processes in cultured adult rat hepatocytes.
    G H Xiao, J A Pinaire, A D Rodrigues and R A Prough
    Drug Metabolism and Disposition June 1995, 23 (6) 642-650;
  • You have access
    Rat brain cytochrome P450. Reassessment of monooxygenase activities and cytochrome P450 levels.
    S V Bhagwat, M R Boyd and V Ravindranath
    Drug Metabolism and Disposition June 1995, 23 (6) 651-654;
  • You have access
    Lymphatic distribution of 3'-azido-3'-deoxythymidine and 3'-azido-2',3'-dideoxyuridine in mice.
    K K Manouilov, C A White, F D Boudinot, I I Fedorov and C K Chu
    Drug Metabolism and Disposition June 1995, 23 (6) 655-658;
  • You have access
    Inhibition of (S)-warfarin metabolism by sulfinpyrazone and its metabolites.
    M He, K L Kunze and W F Trager
    Drug Metabolism and Disposition June 1995, 23 (6) 659-663;
  • You have access
    Increased blood and brain cocaine concentrations with ethanol cotreatment in mice.
    S M Roberts, D L Phillips and I R Tebbett
    Drug Metabolism and Disposition June 1995, 23 (6) 664-666;
  • You have access
    Computer prediction and experimental validation of cytochrome P4502D6-dependent oxidation of GBR 12909.
    M J de Groot, G J Bijloo, K T Hansen and N P Vermeulen
    Drug Metabolism and Disposition June 1995, 23 (6) 667-669;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 23, Issue 6
1 Jun 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics